MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.16897

Медицинская библиотека · Anticancer research · 2024

Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.

Cheevapruk Kodcharat, Ueno Mikinori, Sungwan Prin, Sittithumcharee Gunya, Kariya Ryusho, Sampattavanich Somponnat, Okada Seiji

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIM: Multiple myeloma (MM), the second most common hematological malignancy, is characterized by the accumulation of malignant plasma cells within the bone marrow. Despite various drug classes for MM treatment, it remains incurable, necessitating novel and efficacious agents. This study aims to explore the anti-cancer activity of a midkine inhibitor, iMDK (C21H13FN2O2S), in myeloma cell lines.

MATERIALS AND

METHODS

This study assessed the antiproliferative activity using the MTT assay. Cell cycle and apoptosis were evaluated using flow cytometry. To further investigate the inhibitory mechanism, western blotting was used to detect cell cycle-related proteins, pro-apoptotic proteins, and anti-apoptotic proteins.

RESULTS

iMDK inhibits MM cell proliferation in a dose- and time-dependent manner, inducing cell cycle arrest and apoptosis. The reduction in Cdc20 expression by iMDK treatment leads to G2/M phase cell cycle arrest. Furthermore, iMDK down-regulates anti-apoptotic proteins (Bcl-2, Bcl-xL, Mcl-1, and c-FLIP), thereby activating both intrinsic and extrinsic apoptosis pathways.

CONCLUSION

iMDK could be a potential candidate for MM treatment.

Для цитирования: Cheevapruk Kodcharat, Ueno Mikinori, Sungwan Prin, Sittithumcharee Gunya, Kariya Ryusho, Sampattavanich Somponnat, Okada Seiji. Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.. Anticancer research. 2024. DOI: 10.21873/anticanres.16897.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.